Evidence map›Paper›PMID 30479466›Full record

ArticleWorld journal of gastroenterology2018

Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study.

Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Review
  13. Observational
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Seona ParkDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
Jaeyoung ChunDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
Kyung-Do HanDepartment of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul 06591, South Korea.
Hosim SohDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
Kookhwan ChoiDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
Ji Hye KimDepartment of Internal Medicine, CHA Gangnam Medical Center, CHA University, Seoul 06135, South Korea.
Jooyoung LeeDepartment of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul 06236, South Korea.
Changhyun LeeDepartment of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul 06236, South Korea.
Jong Pil ImDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
Joo Sung KimDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea. jooskim@snu.ac.kr.
CHA University · KRCHA University Gangnam Medical Center · KRCatholic University of Korea · KRSeoul National University · KRSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo estimate the risk of end-stage renal disease (ESRD) in patients with inflammatory bowel disease (IBD).

methodsFrom January 2010 to December 2013, patients with Crohn's disease (CD) and ulcerative colitis (UC) were identified, based on both the International Classification of Diseases, 10

resultsDuring a mean follow-up of 4.9 years, ESRD was detected in 79 (0.2%) patients with IBD and 166 (0.1%) controls. The incidence of ESRD in patients with IBD was 0.42 per 1000 person-years. Patients with IBD had a significantly higher risk of ESRD than controls [adjusted hazard ratio (HR) = 3.03; 95% confidence interval (CI): 1.77-5.20;

conclusionThe risk of ESRD was elevated in patients with CD, but not UC. Patients with CD should be monitored carefully for signs of renal insufficiency.

Indexed as

AdolescentAdultCase-Control StudiesColitis, UlcerativeComorbidityCrohn DiseaseFemaleFollow-Up StudiesHumansIncidenceKidney Failure, ChronicMaleMiddle AgedRepublic of KoreaRetrospective StudiesRisk AssessmentClaims dataCrohn’s diseaseEnd-stage renal diseaseInflammatory bowel diseaseUlcerative colitis

Identifiers

PMID30479466
PMCPMC6235796
OpenAlexW2901641263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.